During the past decade, Ashford Cancer Centre conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ashford Cancer Centre" #1 sponsor was "Australasian Gastro-Intestinal Trials Group" with 3 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "Akesobio Australia Pty Ltd" with 1 trials sponsored, "CStone Pharmaceuticals" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ashford Cancer Centre" #1 collaborator was "Academic and Community Cancer Research United" with 2 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Arbeitsgruppe Lebermetastasen und Tumoren" with 1 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator and "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Ashford Cancer Centre" are "Colorectal Cancer" (2 trials), "Gastro-Oesophageal Cancer" (2 trials), "Pancreatic Cancer" (2 trials), "Advanced Cancer" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Ashford Cancer Centre" in a lesser frequency.

Most popular intervention types in "Ashford Cancer Centre" are "Drug" (13 trials), "Biological" (3 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Regorafenib" (3 trials), "prednisone" (2 trials), "AK-105" (1 trials), "CHOP regimen" (1 trials) and "CS1002" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ashford Cancer Centre" are 13 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ashford Cancer Centre". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ashford Cancer Centre, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ashford Cancer Centre, 3 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".